0.750
-0.05 (-6.11%)
| Previous Close | 0.799 |
| Open | 0.799 |
| Volume | 176,794 |
| Avg. Volume (3M) | 186,780 |
| Market Cap | 8,250,000 |
| Price / Sales | 0.400 |
| Price / Book | 1.75 |
| 52 Weeks Range |
| Profit Margin | 9.19% |
| Operating Margin (TTM) | 9.24% |
| Diluted EPS (TTM) | 0.170 |
| Quarterly Revenue Growth (YOY) | 58.20% |
| Quarterly Earnings Growth (YOY) | 232.70% |
| Total Debt/Equity (MRQ) | 43.88% |
| Current Ratio (MRQ) | 2.46 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Pharmaceutical Retailers (US) | Mixed | Mixed |
| Pharmaceutical Retailers (Global) | Mixed | Bearish | |
| Stock | Hong Kong Pharma Digital Techno | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.50 |
|
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China’s OTC pharmaceutical cross-border e-commerce market. |
|
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Investment Style | Small Core |
| % Held by Insiders | 68.01% |
| % Held by Institutions | 0.47% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 17 Dec 2025 | Announcement | Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |